Document is current
Any future updates will be listed below
-
Authors
Wesener, Darryl A. https://orcid.org/0000-0002-8132-7018
Beller, Zachary W.
Hill, Megan F. https://orcid.org/0000-0001-6128-6338
Yuan, Han
Belanger, David B.
Frankfater, Cheryl
Terrapon, Nicolas https://orcid.org/0000-0002-3693-6017
Henrissat, Bernard https://orcid.org/0000-0002-3434-8588
Rodionov, Dmitry A. https://orcid.org/0000-0002-0939-390X
Leyn, Semen A. https://orcid.org/0000-0002-9886-9120
Osterman, Andrei https://orcid.org/0000-0002-3810-9824
van Hylckama Vlieg, Johan E. T.
Gordon, Jeffrey I. https://orcid.org/0000-0001-8304-3548
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (DK70977)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (DK30292)
Damon Runyon Cancer Research Foundation (DRG-2303-17)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (AT011374)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F30 DK123838)
- License Information
-
More Information
Article History
Received: 3 May 2023
Accepted: 27 September 2024
First Online: 23 October 2024
Competing interests
: A.O. and D.A.R. are co-founders of Phenobiome Inc., a company pursuing development of computational tools for predictive phenotype profiling of microbial communities. H.Y., D.B.B. and J.E.T.v.H.V. were employees of Kaleido Biosciences, a company that sought to commercialize SGs as agents to manipulate human gut bacteria. H.Y. is an inventor on a patent related to the production and use of SGs (US20200390798A1). D.A.W. and J.I.G. are listed as inventors on a patent application related to using particles to measure microbiota enzymatic activities (WO2021016133A1). The other authors declare no competing interests.
